GT Biopharma Inc

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers. GT Biopharma has worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in Brisbane, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers. GT Biopharma has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in San Francisco, CA.

Intec Parent

PAVmed

These Former Penny Stocks Are Turning Heads Ahead Of Robinhood IPO The post 3 Biotech Penny Stocks To Watch On Robinhood IPO Day appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Biotech Penny Stocks To Watch On Robinhood IPO Day

Fate Therapeutics

Teva Pharmaceutical

Hot biotech stocks to watch right now as cancer treatments make headlines in 2021. The post Top Biotech Stocks To Watch After Bristol Myers' Opdivo Sees Q2 Growth appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Biotech Stocks To Watch After Bristol Myers' Opdivo Sees Q2 Growth

Proceeds to Support GTBP Pipeline Drug Development Program BEVERLY HILLS, Calif., July… The post GT Biopharma Announces $16 million in Warrant Exercise Proceeds appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

GT Biopharma Announces $16 million in Warrant Exercise Proceeds.

BEVERLY HILLS, Calif., July 28, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform is pleased to announce the company has raised over $16 million in proceeds from the exercise of warrants.

GT Biopharma Announces $16 million in Warrant Exercise Proceeds

Affimed

Ocugen, Inc.

Former penny stocks biotech analysts are bullish on right now. The post 3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120%

Anavex Life Sciences

Cassava Sciences Inc

Are biotech penny stocks on your watch list in 2021? The post 3 Biotech Penny Stocks To Watch Seeing Explosive Gains In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Biotech Penny Stocks To Watch Seeing Explosive Gains In 2021

IVERIC bio Inc

NRX Pharmaceuticals

Penny Stocks & Small Caps Jump As Biotech Industry Names Kick Into High Gear The post Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech

Cemtrex

Creatd Inc

Origin Agritech

Are traders searching for penny stocks with certain technical traits like SGOC has? The post 4 Hot Penny Stocks To Watch After The 1,100% SGOC Stock Rally appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Hot Penny Stocks To Watch After The 1,100% SGOC Stock Rally

Celldex Therapeutics

Moxian BVI

Why Focus On Penny Stocks? Here Are A Few That Give A Great Answer To That Question.

3 Former Penny Stocks To Watch This Week As Earnings Season Kicks Off

Deepening relationship between GT Biopharma and Dr. Jeffrey Miller TriKE™ improves FT538 iPSC… The post GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota.

Deepening relationship between GT Biopharma and Dr. Jeffrey Miller TriKE™ improves FT538 iPSC NK cells from Fate Therapeutics in prostate cancer model GTB-3550 continues to demonstrate clinical success without significant toxicities BEVERLY HILLS, Calif., July 7, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary NK cell engager (TriKE™) protein biologic technology platform, announced it has entered into a sponsored research agreement (SRA) with Jeffrey S.

GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota

Antares Pharma

ObsEva

Odonate Therapeutics

Palatin Technologies

Seelos Therapeutics

Looking for biotech penny stocks to watch right now? Here are 7 for your list this week.

7 Penny Stocks For Your Watch List This Week If You Like Biotech In July

Dare Bioscience

Second Sight Medical Products

Predictive Oncology Inc

Current & former penny stocks to watch if you like biotech right now. The post Best Penny Stocks For Your July 2021 List?

Best Penny Stocks For Your July 2021 List? 8 Biotechs To Watch Now

Bionano Genomics

MannKind

Mogo

Qumu Corp.

Comscore Inc.

Current & Former Penny Stocks With High Marks From Analysts Right Now. The post 7 Hot Penny Stocks Analysts Like To Watch In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Hot Penny Stocks Analysts Like To Watch In 2021

Centennial Resource Development

National CineMedia

Paratek Pharma

Syros Pharmaceuticals

Do you agree with analysts on these penny stocks? The post 9 Hot Penny Stocks To Watch Right Now, Analyst Targets Up To 290% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

9 Hot Penny Stocks To Watch Right Now, Analyst Targets Up To 290%

BEVERLY HILLS, Calif, June 24, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT… The post GT Biopharma CEO, Tony Cataldo to Present at Sir Anthony Ritossa's Global Family Office Investment Summit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

GT Biopharma CEO, Tony Cataldo to Present at Sir Anthony Ritossa's Global Family Office Investment Summit.

BEVERLY HILLS, Calif, June 24, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that GT Biopharma CEO, Tony Cataldo will be presenting as a VIP speaker at the upcoming Sir Anthony Ritossa's Global Family Office Investment Summit in Monaco from June 30 to July 2, 2021. The Sir Anthony Ritossa's Global Family Office Investment Summit in Monaco is one of a series of international summits held annually as a platform for exceptional networking between Family Offices and Thought Leaders from all over the world.

GT Biopharma CEO, Tony Cataldo to Present at Sir Anthony Ritossa's Global Family Office Investment Summit

Bellerophon Therapeutics

Entera Bio Ltd

Orphazyme A/S

Current & Former Penny Stocks To Watch Before July The post 8 Hot Biotech Penny Stocks For Your July 2021 Watch List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

8 Hot Biotech Penny Stocks For Your July 2021 Watch List

57% of patients experienced significant reduction in AML/MDS cancer cell burden Up… The post GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference.

BEVERLY HILLS, Calif., June 23, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary NK cell engager (TriKE™) protein biologic technology platform, announced Jeffrey S.

GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference

BEVERLY HILLS, Calif., June 21, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that Dr. Jeffrey S.

Dr. Jeffrey S. Miller to Present on Progress of GTB-3550 TriKE™ Phase I Trial Accompanying GT Biopharma's Company Presentation at Raymond James Human Health Innovation Conference

Workhorse Group

These former penny stocks have followed the path of AMC stock this month The post 3 Penny Stocks To Watch As AMC Stock Makes Headlines In June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks To Watch As AMC Stock Makes Headlines In June 2021

BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT… The post GT Biopharma to Present at Raymond James Human Health Innovation Conference appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

GT Biopharma to Present at Raymond James Human Health Innovation Conference.

BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that it will provide a corporate update at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET.

GT Biopharma to Present at Raymond James Human Health Innovation Conference

Asensus Surgical

Atossa Genetics

Citius Pharmaceuticals

If biotech penny stocks are your focus, check these 4 out right now The post 4 Top Biotech Penny Stocks To Watch In The Second Half Of June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Biotech Penny Stocks To Watch In The Second Half Of June 2021

News for GT Biopharma Inc Stock (GTBP)